Literature DB >> 11025718

Results of transurethral injection of silicone micro-implants for females with intrinsic sphincter deficiency.

E Barranger1, X Fritel, O Kadoch, Y Liou, A Pigné.   

Abstract

PURPOSE: We evaluated the medium term efficiency of silicone micro-implants injected in women with intrinsic sphincter deficiency.
MATERIALS AND METHODS: A total of 21 women with intrinsic sphincter deficiency underwent transurethral injection of silicone micro-implants between August 1996 and February 1997. Each patient was assessed preoperatively by questionnaire, physical examination and urodynamic study. The results were evaluated by questionnaire at 1 month, and 1 and 2 years after silicone injection. The outcome was classified as dry in all circumstances, improved or failure.
RESULTS: All patients (median age 68 years, range 46 to 83) had undergone previous anti-incontinence or prolapse surgeries. At 1 month 2 patients (10%) were dry and 9 (42%) were improved, and treatment failed in 10 (48%). At 1 year (median 16 months, range 14 to 22) 2 cases (10%) were classified as dry, 8 (38%) improved and 11 (52%) failures. At last followup (median 31 months, range 24 to 34) 4 cases (19%) were classified as dry, 6 (29%) improved and 11 (52%) failures. None of the 6 patients with bladder neck hypermobility was dry.
CONCLUSIONS: Our results of silicone transurethral injection are disappointing but comparable to other bulking agents without a time dependent decrease in efficiency. The use of silicone micro-implants is an alternative for the treatment of intrinsic sphincter deficiency in patients without bladder neck hypermobility and in whom the sling procedure has failed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11025718

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  11 in total

1.  Transurethral injection of bulking agent for treatment of failed mid-urethral sling procedures.

Authors:  Ha Na Lee; Young-Suk Lee; Ji-Yeon Han; Jae Yong Jeong; Myung-Soo Choo; Kyu-Sung Lee
Journal:  Int Urogynecol J       Date:  2010-07-20       Impact factor: 2.894

2.  Current use of injectable agents for female stress urinary incontinence.

Authors:  Sender Herschorn
Journal:  Rev Urol       Date:  2005

Review 3.  Treatment options for intrinsic sphincter deficiency.

Authors:  Sovrin M Shah; Geoffrey S Gaunay
Journal:  Nat Rev Urol       Date:  2012-10-02       Impact factor: 14.432

4.  The female continence mechanism measured by high resolution manometry: Urethral bulking versus midurethral sling.

Authors:  Erika J Wasenda; Anna C Kirby; Emily S Lukacz; Charles W Nager
Journal:  Neurourol Urodyn       Date:  2018-02-21       Impact factor: 2.696

Review 5.  Patient-perceived outcomes in the treatment of stress urinary incontinence: focus on urethral injection therapy.

Authors:  Christopher R Chapple; Linda Brubaker; François Haab; Philip van Kerrebroeck; Dudley Robinson
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-07-18

6.  Where should bulking agents for female urodynamic stress incontinence be injected?

Authors:  Annette Kuhn; Werner Stadlmayr; Daniela Lengsfeld; Michel D Mueller
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-06

7.  Long-term results and patients' satisfaction after transurethral ethylene vinyl alcohol (Tegress) injections: a two-centre study.

Authors:  Annette Kuhn; Werner Stadlmayr; Amara Sohail; Ash Monga
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-10-23

8.  Comparison between porcine dermal implant (Permacol) and silicone injection (Macroplastique) for urodynamic stress incontinence.

Authors:  F Bano; J W Barrington; R Dyer
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2004-09-18

Review 9.  A systematic review and meta-analysis of Macroplastique for treating female stress urinary incontinence.

Authors:  Gamal M Ghoniem; Christopher J Miller
Journal:  Int Urogynecol J       Date:  2012-06-15       Impact factor: 2.894

Review 10.  Injectable agents: present and future.

Authors:  Deborah J Lightner; Nancy B Itano; Susan D Sweat; Kristin L Chrouser; Felecia Fick
Journal:  Curr Urol Rep       Date:  2002-10       Impact factor: 2.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.